Multimodal monitoring, Intracranial dynamics and Neuro-oncology Workstream

Screen Shot 2015-09-24 at 15.29.35Multimodality monitoring Lead
Professor Peter Hutchinson is an NIHR Researcher at the Department of Clinical Neurosciences, University of Cambridge and Honorary Consultant Neurosurgeon at Addenbrooke’s Hospital, Cambridge.

His research interests include multimodality monitoring in traumatic brain injury and has projects in 3D printing cranioplasty, clinical utility of microdialysis and the ICP monitoring in paediatrics (ICM+).

Screen Shot 2015-09-24 at 15.29.45

Intracranial dynamics Lead
Professor Marek Czosnyka (left) and Dr. Peter Smielewski (right) study the physical interactions between volumes, flows and pressures in the brain. Their on-going research collectively investigates the intracranial dynamics of TBI informing the continuous development of ICM+, software enabling the collection and analysis of bedside monitoring data capable of alerting medical staff to the development of brain pathological processes.

Screen Shot 2015-09-24 at 15.29.53

Neuro-Oncology Lead
Dr. Stephen Price is an NIHR Clinician Scientist and Honorary Consultant Neurosurgeon with Cambridge University Hospitals. He qualified from St Bartholomew’s Hospital, London and gained his PhD in 2007 from Clare College, Cambridge. He is a member of the National Cancer Research Institute Brain Tumour Clinical Study Group, their Imaging and Technology sub-group and in 2013 became the Network Lead for CNS Tumours at the Anglian Cancer Network. He is Director of Studies for Clinical Medicine and Bye-Fellow at Queen’s College, Cambridge and is an East of England Senate Member and Innovation Lead for the Neuro-Oncology Clinical Reference Group. In February 2013 he was the Visiting Professor of Neurosurgery at Acibadem University, Istanbul.

Dr. Price’s research focuses on Intertumoural heterogeneity and Intratumoural heterogeneity and he has, over his career, been awarded ten research grants, including currently two from Cancer Research UK (Brain Tumour Imaging and Biomarkers and Imaging Discovery and Development) and The Brain Tumour Charity (Quantitative diffusion imaging for early treatment, response and progression evaluation in adult high grade gliomas), together worth over 7.9 million. He introduced 5-ALA fluorescence guided surgery, which he now helps teach to others and in 2014 he won the BrainLab Neurosurgery Award from the Congress of Neurological Sciences.


Supported projects